Potential conflict of interest: Nothing to report.
Version of Record online: 4 DEC 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 56, Issue 6, pages 2277–2287, December 2012
How to Cite
Tsao, C.-M., Yan, M.-D., Shih, Y.-L., Yu, P.-N., Kuo, C.-C., Lin, W.-C., Li, H.-J. and Lin, Y.-W. (2012), SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatology, 56: 2277–2287. doi: 10.1002/hep.25933
Supported in part by grants NSC 99-3112-B-016-003, NSC 99-2314-B-016-015-MY2, NSC 100-2320-B-016-011, and NSC 101-2320-B-016-011 from the National Science Council, Taiwan, Republic of China, and by the Liver Disease Prevention and Treatment Research Foundation, Taiwan, Republic of China.
- Issue online: 4 DEC 2012
- Version of Record online: 4 DEC 2012
- Accepted manuscript online: 5 JUL 2012 11:43AM EST
- Manuscript Accepted: 14 JUN 2012
- Manuscript Received: 30 APR 2012
- National Science Council, Taiwan, Republic of China. Grant Numbers: NSC 99-3112-B-016-003, NSC 99-2314-B-016-015-MY2, NSC 100-2320-B-016-011, NSC 101-2320-B-016-011
- Liver Disease Prevention and Treatment Research Foundation, Taiwan, Republic of China
Additional Supporting Information may be found in the online version of this article.
|HEP_25933_sm_SuppFig1.tif||5150K||Supporting Information Figure 1. (A) Increased SOX1 expression dramatically suppressed anchorage-independent growth (AIG) of HepG2, Huh7 and SK-Hep-1 cells. The representative photographs were taken after 4 weeks of incubation and the number of colonies was measured. (B) Elevated SOX1 expression inhibited the invasion ability of SK-Hep-1 and HA22T cells. A representative photograph of invasive cells on the lower surface of the insert is shown.|
|HEP_25933_sm_SuppFig2.tif||649K||Supporting Information Figure 2. Tumors harvested on day 38 after implantation were used to verify the level of SOX1 expression by Western blot. β-actin was used as a loading control.|
|HEP_25933_sm_SuppFig3.tif||463K||Supporting Information Figure 3. Time- and dose-dependent induction of SOX1 protein expression by doxycycline. (A) DOX (0, 0.01, 0.1,1 and 10 μg/ml) was applied to cells for 48 hr. (B) Hep3B cells were treated with DOX (1 μg/ml) for 0, 12, 24, 48 and 72 h. Cell lysates were subjected to Western blot analysis. β-actin was used as a loading control.|
|HEP_25933_sm_SuppFig4.tif||2609K||Supporting Information Figure 4. (A) Inducible SOX1 expression dramatically suppressed anchorage-independent growth of HepG2, Huh7 and SK-Hep-1 cells. The representative photographs were taken after 4 weeks of incubation and the numbers of colonies were measured. (B) A Matrigel invasion assay was performed in SK-Hep-1 cells inductively expressing SOX1 by treatment with doxycycline 1 μg/ml for 3 days. The cells were then placed in a Matrigel-coated Boyden chamber and allowed to invade for 24 hr. A representative photograph of invasive cells on the lower surface of the insert is shown.|
|HEP_25933_sm_SuppFig5.tif||1346K||Supporting Information Figure 5. (A) The SOX1 protein levels expressed inductively by 1 μg/ml DOX for 7 days (DOX+) and then withdrawal of DOX for a further 7 days (DOX withdrawal) were investigated by Western blot. (B) A representative photograph of the AIG assay from cells treated as described in (A) is shown.|
|HEP_25933_sm_SuppFig6.tif||1236K||Supporting Information Figure 6. GST pull-down assay. Purified GST only or GST-SOX1 proteins were immobilized on a glutathione-sepharose column and mixed with lysate from Huh6 cells. After washing and elution, the remaining proteins were analyzed by Western blot using anti-β-catenin and anti-GST antibodies.|
|HEP_25933_sm_SuppFig7.tif||1588K||Supporting Information Figure 7. Truncated Flag-SOX1 suppresses ß-catenin-mediated TCF/LEF signaling. (A) Full-length Flag-SOX1 and truncated Flag-SOX1 as indicated were established and shown by Western blot from COS7 cells. (B) Huh6, Hep3B and HepG2 cells were transfected with Flag-tagged plasmids as indicated and the TOPFLASH reporter gene and dual-luciferase activities were measured as described above. The data showed that full-length Flag-SOX1, Flag-?N-SOX1 and Flag-?C-SOX1 could suppress ß-catenin-mediated TCF/LEF signaling with an efficiency comparable with that of Flag-Vector, whereas Flag-C-SOX1 could not suppress it. The luciferase activity was normalized to the Renilla luciferase activity. The results are presented as the mean ± SE. Experiments were performed in triplicate. Significant differences are indicated by asterisks; (*) for P < 0.05 and (*) for P < 0.01.|
|HEP_25933_sm_SuppTab1.tif||6461K||Supporting Information Table 1.|
|HEP_25933_sm_SuppTab2.doc||69K||Supporting Information Table 2. Correlation between SOX1 expression and clinicopathologic characteristics|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.